Milligan, P. 2021. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study. [Online]. London School of Hygiene & Tropical Medicine, London, United Kingdom. Available from: https://doi.org/10.17037/DATA.00002136.
Milligan, P. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study [Internet]. London School of Hygiene & Tropical Medicine; 2021. Available from: https://doi.org/10.17037/DATA.00002136.
Milligan, P (2021). Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study. [Data Collection]. London School of Hygiene & Tropical Medicine, London, United Kingdom. https://doi.org/10.17037/DATA.00002136.
Description
Seasonal malaria chemoprevention (SMC) aims to prevent malaria in children during the high malaria transmission season. The Achieving Catalytic Expansion of SMC in the Sahel (ACCESS-SMC) project sought to remove barriers to the scale-up of SMC in seven countries in 2015 and 2016. We evaluated the project, including coverage, effectiveness of the intervention, safety, feasibility, drug resistance, and cost-effectiveness. For this observational study, we collected data on the delivery, effectiveness, safety, influence on drug resistance, costs of delivery, impact on malaria incidence and mortality, and cost-effectiveness of SMC, during its administration for 4 months each year (2015 and 2016) to children younger than 5 years, in Burkina Faso, Chad, The Gambia, Guinea, Mali, Republic of the Niger, and Nigeria. SMC was administered monthly by community health workers who visited door-to-door. Drug administration was monitored via tally sheets and via household cluster-sample coverage surveys. Pharmacovigilance was based on targeted spontaneous reporting and monitoring systems were strengthened. Molecular markers of resistance to sulfadoxine–pyrimethamine and amodiaquine in the general population before and 2 years after SMC introduction was assessed from community surveys. Effectiveness of monthly SMC treatments was measured in case-control studies that compared receipt of SMC between patients with confirmed malaria and neighbourhood-matched community controls eligible to receive SMC. Impact on incidence and mortality was assessed from confirmed outpatient cases, hospital admissions, and deaths associated with malaria, as reported in national health management information systems in Burkina Faso and The Gambia, and from data from selected outpatient facilities (all countries). Provider costs of SMC were estimated from financial costs, costs of health-care staff time, and volunteer opportunity costs, and cost-effectiveness ratios were calculated as the total cost of SMC in each country divided by the predicted number of cases averted. This collection contains data collected as part of the SMC coverage surveys, case control studies, malaria incidence at health facilities, and molecular markers of resistance, as well as the accompanying protocols, reports, and tools produced by the Access-SMC study. Please consult the file listing for further information.
Additional information
This collection contains data collected as part of the SMC coverage surveys, case control studies, malaria incidence at health facilities, and molecular markers of resistance, as well as the accompanying protocols, reports, and tools produced by the Access-SMC study. Please consult the file listing for further information.
Keywords
Description of data capture | Coverage surveys: household survey questionnaires Case control studies: questionnaires Molecular marker surveys: survey questionnaires and lab data Impact: health facility data on confirmed malaria cases from clinic registers | ||||
---|---|---|---|---|---|
Data capture method | Questionnaire | ||||
Data Collection Period |
|
||||
Date (Date submitted to LSHTM repository) | 25 March 2021 | ||||
Language(s) of written materials | English, French |
Data Creators | Milligan, P |
---|---|
LSHTM Faculty/Department | Faculty of Epidemiology and Population Health > Dept of Infectious Disease Epidemiology |
Research Centre | Malaria Centre |
Participating Institutions | London School of Hygiene & Tropical Medicine, London, United Kingdom, Malaria Consortium, Catholic Relief Services, United States, Medicines for Malaria Venture, Geneva, Switzerland, Speak Up Africa, Management Sciences for Health |
Funders |
|
---|
Date Deposited | 10 Sep 2021 10:13 |
---|---|
Last Modified | 13 Sep 2021 16:36 |
Publisher | London School of Hygiene & Tropical Medicine |
Downloads
Data / Code
Restricted to: Request access for all
Filename: Access-SMC-datasets.zip
Description: Data on coverage, efficacy, resistance and impact from the ACCESS-SMC evaluation. Please contact study team directly to discuss datasets
Licence: Data Sharing Agreement
Content type: Dataset
File size: 231B
Mime-Type: application/zip
Documentation
Restricted to: Request access for all
Filename: SMC_Evaluation_Protocol.pdf
Description: ACCESS-SMC Evaluation Protocol v1.6 (June 2021)
Content type: Textual content
File size: 1MB
Mime-Type: application/pdf
Restricted to: Request access for all
Filename: SMC_Coverage_Report.pdf
Description: ACCESS-SMC evaluation final report: Seasonal malaria chemoprevention coverage in seven West African countries, 2015-2016 (June 2018)
Content type: Textual content
File size: 2MB
Mime-Type: application/pdf
Restricted to: Request access for all
Filename: SMC_DrugResistance_Baseline_Report.pdf
Description: ACCESS-SMC Evaluation: Assessment of the frequency of molecular markers associated with resistance to SP+AQ in seven countries before scaling up of seasonal malaria chemoprevention
Content type: Textual content
File size: 1MB
Mime-Type: application/pdf
Restricted to: Request access for all
Filename: SMC_DrugResistance_Survey_Report.pdf
Description: ACCESS-SMC Drug Resistance Survey Report: Assessment of the frequency of molecular markers associated with resistance to SMC drugs in 7 countries after two years of SMC at scale (Feb 10 2020)
Content type: Textual content
File size: 569kB
Mime-Type: application/pdf
Restricted to: Request access for all
Filename: SMC_Efficacy_Report.pdf
Description: ACCESS-SMC evaluation: Assessment of the protective efficacy of Seasonal Malaria Chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine in Burkina Faso, Chad, The Gambia, Mali and Nigeria, 2015-2016
Content type: Textual content
File size: 874kB
Mime-Type: application/pdf
Restricted to: Request access for all
Filename: SMC_Impact_Report.pdf
Description: ACCESS-SMC evaluation: Assessment of the impact of ACCESS-SMC on malaria cases and deaths in 2015 and 2016
Content type: Textual content
File size: 3MB
Mime-Type: application/pdf
Restricted to: Request access for all
Filename: SMC_Safety_Monitoring_Report.pdf
Description: ACCESS-SMC evaluation: Monitoring the safety of Seasonal Malaria Chemoprevention during large scale implementation through the ACCESS-SMC project 2015-16
Content type: Textual content
File size: 2MB
Mime-Type: application/pdf
Filename: 2136-UserGuide.html
Description: User guide for the collection
Content type: Textual content
File size: 11kB
Mime-Type: text/html
Study Instrument
Restricted to: Request access for all
Filename: Access-SMC-Tools.zip
Description: Zip file that contains job aids for Pharmacovigilance, Open Data Kit questionnaire for coverage surveys (v0.5), and the Standard Operating Procedures (SOP) for the SMC case control studies
Licence: Data Sharing Agreement
Content type: Textual content
File size: 1MB
Mime-Type: application/zip